APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epigenetics NGS Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Epigenetics NGS Service Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchEpigenetics NGS Service Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Epigenetics NGS Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Epigenetics NGS Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epigenetics NGS Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Epigenetics NGS Service Market Analysis and Forecast 2026-2032186 pages · $4,950 USD

Market perspective

The global Epigenetics NGS Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Epigenetics NGS Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Epigenetics NGS Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Epigenetics NGS Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Epigenetics NGS Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Epigenetics NGS Service market include Active Motif, Agilent, Zymo Research, Celemics, EpiGentek, GENEWIZ from Azenta, Thermo Fisher Scientific, GenomeScan and Hologic Diagenode, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Epigenetics NGS Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Epigenetics NGS Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Epigenetics NGS Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Epigenetics NGS Service market.

Epigenetics NGS Service Segment by Company

Active Motif

Agilent

Zymo Research

Celemics

EpiGentek

GENEWIZ from Azenta

Thermo Fisher Scientific

GenomeScan

Hologic Diagenode

Illumina

Macrogen

Novogene

Roche Sequencing Solutions

SeqMatic

Epigenetics NGS Service Segment by Type

DNA Methylation Sequencing

Histone Modification Sequencing

3D Genome Sequencing

Others

Epigenetics NGS Service Segment by Application

Clinical Diagnostics

Basic Research

Drug Development

Agricultural Breeding

Others

Epigenetics NGS Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Epigenetics NGS Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Epigenetics NGS Service key companies, revenue, market share, and recent developments.

3. To split the Epigenetics NGS Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Epigenetics NGS Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Epigenetics NGS Service significant trends, drivers, influence factors in global and regions.

6. To analyze Epigenetics NGS Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenetics NGS Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epigenetics NGS Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenetics NGS Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Epigenetics NGS Service industry.

Chapter 3: Detailed analysis of Epigenetics NGS Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Epigenetics NGS Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Epigenetics NGS Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Epigenetics NGS Service Industry Trends Table 2. Epigenetics NGS Service Industry Drivers Table 3. Epigenetics NGS Service Industry Opportunities and Challenges Table 4. Epigenetics NGS Service Industry Restraints Table 5. Global Epigenetics NGS Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Epigenetics NGS Service Revenue Share by Company (2021-2026) Table 7. Global Epigenetics NGS Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Epigenetics NGS Service Key Company Manufacturing Base & Headquarters Table 9. Global Epigenetics NGS Service Company, Product Type & Application Table 10. Global Epigenetics NGS Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Epigenetics NGS Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of DNA Methylation Sequencing Table 15. Significant Companies of Histone Modification Sequencing Table 16. Significant Companies of 3D Genome Sequencing Table 17. Significant Companies of Others Table 18. Global Epigenetics NGS Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Epigenetics NGS Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Epigenetics NGS Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Epigenetics NGS Service Sales Value Share by Type (2021-2026) Table 22. Global Epigenetics NGS Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Clinical Diagnostics Table 24. Significant Companies of Basic Research Table 25. Significant Companies of Drug Development Table 26. Significant Companies of Agricultural Breeding Table 27. Significant Companies of Others Table 28. Global Epigenetics NGS Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Epigenetics NGS Service Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Epigenetics NGS Service Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Epigenetics NGS Service Sales Value Share by Application (2021-2026) Table 32. Global Epigenetics NGS Service Sales Value Share by Application (2027-2032) Table 33. Global Epigenetics NGS Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Epigenetics NGS Service Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Epigenetics NGS Service Sales Value Share by Region (2021-2026) Table 36. Global Epigenetics NGS Service Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Epigenetics NGS Service Sales Value Share by Region (2027-2032) Table 38. Global Epigenetics NGS Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Epigenetics NGS Service Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Epigenetics NGS Service Sales Value Market Share by Country (2021-2026) Table 41. Global Epigenetics NGS Service Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Epigenetics NGS Service Sales Value Market Share by Country (2027-2032) Table 43. Active Motif Company Information Table 44. Active Motif Business Overview Table 45. Active Motif Epigenetics NGS Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Active Motif Epigenetics NGS Service Product Portfolio Table 47. Active Motif Recent Development Table 48. Agilent Company Information Table 49. Agilent Business Overview Table 50. Agilent Epigenetics NGS Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Agilent Epigenetics NGS Service Product Portfolio Table 52. Agilent Recent Development Table 53. Zymo Research Company Information Table 54. Zymo Research Business Overview Table 55. Zymo Research Epigenetics NGS Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Zymo Research Epigenetics NGS Service Product Portfolio Table 57. Zymo Research Recent Development Table 58. Celemics Company Information Table 59. Celemics Business Overview Table 60. Celemics Epigenetics NGS Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Celemics Epigenetics NGS Service Product Portfolio Table 62. Celemics Recent Development Table 63. EpiGentek Company Information Table 64. EpiGentek Business Overview Table 65. EpiGentek Epigenetics NGS Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. EpiGentek Epigenetics NGS Service Product Portfolio Table 67. EpiGentek Recent Development Table 68. GENEWIZ from Azenta Company Information Table 69. GENEWIZ from Azenta Business Overview Table 70. GENEWIZ from Azenta Epigenetics NGS Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. GENEWIZ from Azenta Epigenetics NGS Service Product Portfolio Table 72. GENEWIZ from Azenta Recent Development Table 73. Thermo Fisher Scientific Company Information Table 74. Thermo Fisher Scientific Business Overview Table 75. Thermo Fisher Scientific Epigenetics NGS Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Thermo Fisher Scientific Epigenetics NGS Service Product Portfolio Table 77. Thermo Fisher Scientific Recent Development Table 78. GenomeScan Company Information Table 79. GenomeScan Business Overview Table 80. GenomeScan Epigenetics NGS Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. GenomeScan Epigenetics NGS Service Product Portfolio Table 82. GenomeScan Recent Development Table 83. Hologic Diagenode Company Information Table 84. Hologic Diagenode Business Overview Table 85. Hologic Diagenode Epigenetics NGS Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hologic Diagenode Epigenetics NGS Service Product Portfolio Table 87. Hologic Diagenode Recent Development Table 88. Illumina Company Information Table 89. Illumina Business Overview Table 90. Illumina Epigenetics NGS Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Illumina Epigenetics NGS Service Product Portfolio Table 92. Illumina Recent Development Table 93. Macrogen Company Information Table 94. Macrogen Business Overview Table 95. Macrogen Epigenetics NGS Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Macrogen Epigenetics NGS Service Product Portfolio Table 97. Macrogen Recent Development Table 98. Novogene Company Information Table 99. Novogene Business Overview Table 100. Novogene Epigenetics NGS Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Novogene Epigenetics NGS Service Product Portfolio Table 102. Novogene Recent Development Table 103. Roche Sequencing Solutions Company Information Table 104. Roche Sequencing Solutions Business Overview Table 105. Roche Sequencing Solutions Epigenetics NGS Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Roche Sequencing Solutions Epigenetics NGS Service Product Portfolio Table 107. Roche Sequencing Solutions Recent Development Table 108. SeqMatic Company Information Table 109. SeqMatic Business Overview Table 110. SeqMatic Epigenetics NGS Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. SeqMatic Epigenetics NGS Service Product Portfolio Table 112. SeqMatic Recent Development Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Epigenetics NGS Service Product Image Figure 2. Global Epigenetics NGS Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Epigenetics NGS Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Epigenetics NGS Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. DNA Methylation Sequencing Image Figure 8. Histone Modification Sequencing Image Figure 9. 3D Genome Sequencing Image Figure 10. Others Image Figure 11. Global Epigenetics NGS Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Epigenetics NGS Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Epigenetics NGS Service Sales Value Share by Type (2021-2032) Figure 14. Clinical Diagnostics Image Figure 15. Basic Research Image Figure 16. Drug Development Image Figure 17. Agricultural Breeding Image Figure 18. Others Image Figure 19. Global Epigenetics NGS Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Epigenetics NGS Service Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Epigenetics NGS Service Sales Value Share by Application (2021-2032) Figure 22. Global Epigenetics NGS Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Epigenetics NGS Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Epigenetics NGS Service Sales Value (2021-2032) & (US$ Million) Figure 25. North America Epigenetics NGS Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Epigenetics NGS Service Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Epigenetics NGS Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Epigenetics NGS Service Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Epigenetics NGS Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Epigenetics NGS Service Sales Value (2021-2032) & (US$ Million) Figure 31. South America Epigenetics NGS Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Epigenetics NGS Service Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Epigenetics NGS Service Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Epigenetics NGS Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Methylation Sequencing
  • Histone Modification Sequencing
  • 3D Genome Sequencing
  • Others
Applications
  • Clinical Diagnostics
  • Basic Research
  • Drug Development
  • Agricultural Breeding
  • Others
Companies covered
  • Active Motif
  • Agilent
  • Zymo Research
  • Celemics
  • EpiGentek
  • GENEWIZ from Azenta
  • Thermo Fisher Scientific
  • GenomeScan
  • Hologic Diagenode
  • Illumina
  • Macrogen
  • Novogene
  • Roche Sequencing Solutions
  • SeqMatic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Epigenetics NGS Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Epigenetics NGS Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Epigenetics NGS Service Market Dynamics
  1. 2.1 Epigenetics NGS Service Industry Trends
  2. 2.2 Epigenetics NGS Service Industry Drivers
  3. 2.3 Epigenetics NGS Service Industry Opportunities and Challenges
  4. 2.4 Epigenetics NGS Service Industry Restraints
3 Epigenetics NGS Service Market by Company
  1. 3.1 Global Epigenetics NGS Service Company Revenue Ranking in 2025
  2. 3.2 Global Epigenetics NGS Service Revenue by Company (2021-2026)
  3. 3.3 Global Epigenetics NGS Service Company Ranking (2024-2026)
  4. 3.4 Global Epigenetics NGS Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Epigenetics NGS Service Company Product Type and Application
  6. 3.6 Global Epigenetics NGS Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Epigenetics NGS Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Epigenetics NGS Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Epigenetics NGS Service Market by Type
  1. 4.1 Epigenetics NGS Service Type Introduction
  2. 4.1.1 DNA Methylation Sequencing
  3. 4.1.2 Histone Modification Sequencing
  4. 4.1.3 3D Genome Sequencing
  5. 4.1.4 Others
  6. 4.2 Global Epigenetics NGS Service Sales Value by Type
  7. 4.2.1 Global Epigenetics NGS Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Epigenetics NGS Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Epigenetics NGS Service Sales Value Share by Type (2021-2032)
5 Epigenetics NGS Service Market by Application
  1. 5.1 Epigenetics NGS Service Application Introduction
  2. 5.1.1 Clinical Diagnostics
  3. 5.1.2 Basic Research
  4. 5.1.3 Drug Development
  5. 5.1.4 Agricultural Breeding
  6. 5.1.5 Others
  7. 5.2 Global Epigenetics NGS Service Sales Value by Application
  8. 5.2.1 Global Epigenetics NGS Service Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Epigenetics NGS Service Sales Value by Application (2021-2032)
  10. 5.2.3 Global Epigenetics NGS Service Sales Value Share by Application (2021-2032)
6 Epigenetics NGS Service Regional Value Analysis
  1. 6.1 Global Epigenetics NGS Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Epigenetics NGS Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Epigenetics NGS Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Epigenetics NGS Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Epigenetics NGS Service Sales Value (2021-2032)
  7. 6.3.2 North America Epigenetics NGS Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Epigenetics NGS Service Sales Value (2021-2032)
  10. 6.4.2 Europe Epigenetics NGS Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Epigenetics NGS Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Epigenetics NGS Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Epigenetics NGS Service Sales Value (2021-2032)
  16. 6.6.2 South America Epigenetics NGS Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Epigenetics NGS Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Epigenetics NGS Service Sales Value Share by Country, 2025 VS 2032
7 Epigenetics NGS Service Country-level Value Analysis
  1. 7.1 Global Epigenetics NGS Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Epigenetics NGS Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Epigenetics NGS Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Epigenetics NGS Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Epigenetics NGS Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Epigenetics NGS Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Epigenetics NGS Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Active Motif
  2. 8.1.1 Active Motif Company Information
  3. 8.1.2 Active Motif Business Overview
  4. 8.1.3 Active Motif Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Active Motif Epigenetics NGS Service Product Portfolio
  6. 8.1.5 Active Motif Recent Developments
  7. 8.2 Agilent
  8. 8.2.1 Agilent Company Information
  9. 8.2.2 Agilent Business Overview
  10. 8.2.3 Agilent Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Agilent Epigenetics NGS Service Product Portfolio
  12. 8.2.5 Agilent Recent Developments
  13. 8.3 Zymo Research
  14. 8.3.1 Zymo Research Company Information
  15. 8.3.2 Zymo Research Business Overview
  16. 8.3.3 Zymo Research Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zymo Research Epigenetics NGS Service Product Portfolio
  18. 8.3.5 Zymo Research Recent Developments
  19. 8.4 Celemics
  20. 8.4.1 Celemics Company Information
  21. 8.4.2 Celemics Business Overview
  22. 8.4.3 Celemics Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Celemics Epigenetics NGS Service Product Portfolio
  24. 8.4.5 Celemics Recent Developments
  25. 8.5 EpiGentek
  26. 8.5.1 EpiGentek Company Information
  27. 8.5.2 EpiGentek Business Overview
  28. 8.5.3 EpiGentek Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 EpiGentek Epigenetics NGS Service Product Portfolio
  30. 8.5.5 EpiGentek Recent Developments
  31. 8.6 GENEWIZ from Azenta
  32. 8.6.1 GENEWIZ from Azenta Company Information
  33. 8.6.2 GENEWIZ from Azenta Business Overview
  34. 8.6.3 GENEWIZ from Azenta Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GENEWIZ from Azenta Epigenetics NGS Service Product Portfolio
  36. 8.6.5 GENEWIZ from Azenta Recent Developments
  37. 8.7 Thermo Fisher Scientific
  38. 8.7.1 Thermo Fisher Scientific Company Information
  39. 8.7.2 Thermo Fisher Scientific Business Overview
  40. 8.7.3 Thermo Fisher Scientific Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Thermo Fisher Scientific Epigenetics NGS Service Product Portfolio
  42. 8.7.5 Thermo Fisher Scientific Recent Developments
  43. 8.8 GenomeScan
  44. 8.8.1 GenomeScan Company Information
  45. 8.8.2 GenomeScan Business Overview
  46. 8.8.3 GenomeScan Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GenomeScan Epigenetics NGS Service Product Portfolio
  48. 8.8.5 GenomeScan Recent Developments
  49. 8.9 Hologic Diagenode
  50. 8.9.1 Hologic Diagenode Company Information
  51. 8.9.2 Hologic Diagenode Business Overview
  52. 8.9.3 Hologic Diagenode Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hologic Diagenode Epigenetics NGS Service Product Portfolio
  54. 8.9.5 Hologic Diagenode Recent Developments
  55. 8.10 Illumina
  56. 8.10.1 Illumina Company Information
  57. 8.10.2 Illumina Business Overview
  58. 8.10.3 Illumina Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Illumina Epigenetics NGS Service Product Portfolio
  60. 8.10.5 Illumina Recent Developments
  61. 8.11 Macrogen
  62. 8.11.1 Macrogen Company Information
  63. 8.11.2 Macrogen Business Overview
  64. 8.11.3 Macrogen Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Macrogen Epigenetics NGS Service Product Portfolio
  66. 8.11.5 Macrogen Recent Developments
  67. 8.12 Novogene
  68. 8.12.1 Novogene Company Information
  69. 8.12.2 Novogene Business Overview
  70. 8.12.3 Novogene Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Novogene Epigenetics NGS Service Product Portfolio
  72. 8.12.5 Novogene Recent Developments
  73. 8.13 Roche Sequencing Solutions
  74. 8.13.1 Roche Sequencing Solutions Company Information
  75. 8.13.2 Roche Sequencing Solutions Business Overview
  76. 8.13.3 Roche Sequencing Solutions Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Roche Sequencing Solutions Epigenetics NGS Service Product Portfolio
  78. 8.13.5 Roche Sequencing Solutions Recent Developments
  79. 8.14 SeqMatic
  80. 8.14.1 SeqMatic Company Information
  81. 8.14.2 SeqMatic Business Overview
  82. 8.14.3 SeqMatic Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 SeqMatic Epigenetics NGS Service Product Portfolio
  84. 8.14.5 SeqMatic Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst